GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » LT-Debt-to-Total-Asset

AMIX (Autonomix Medical) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Autonomix Medical's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Autonomix Medical's long-term debt to total assets ratio declined from Dec. 2023 (0.81) to Dec. 2024 (0.00). It may suggest that Autonomix Medical is progressively becoming less dependent on debt to grow their business.


Autonomix Medical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Autonomix Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical LT-Debt-to-Total-Asset Chart

Autonomix Medical Annual Data
Trend Mar23 Mar24
LT-Debt-to-Total-Asset
- 0.11

Autonomix Medical Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 0.81 0.11 0.15 0.20 -

Autonomix Medical LT-Debt-to-Total-Asset Calculation

Autonomix Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=1.002/9.407
=

Autonomix Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0/11.952
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Autonomix Medical  (NAS:AMIX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Autonomix Medical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Autonomix Medical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Autonomix Medical Business Description

Traded in Other Exchanges
N/A
Address
21 Waterway Avenue, Suite 300, Woodlands, TX, USA, 77380
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Autonomix Medical Headlines

From GuruFocus

Autonomix Announces Reverse Stock Split

By Marketwired 10-22-2024